nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—CYP1A1—breast cancer	0.105	0.42	CbGaD
Sildenafil—CYP2D6—breast cancer	0.0784	0.312	CbGaD
Sildenafil—CYP3A4—breast cancer	0.0672	0.268	CbGaD
Sildenafil—ABCC10—Gemcitabine—breast cancer	0.0369	0.0795	CbGbCtD
Sildenafil—ABCC10—Paclitaxel—breast cancer	0.0334	0.0718	CbGbCtD
Sildenafil—ABCC5—Fluorouracil—breast cancer	0.0316	0.068	CbGbCtD
Sildenafil—CYP1A1—Toremifene—breast cancer	0.028	0.0602	CbGbCtD
Sildenafil—ABCC10—Docetaxel—breast cancer	0.0241	0.0519	CbGbCtD
Sildenafil—ABCC10—Doxorubicin—breast cancer	0.018	0.0387	CbGbCtD
Sildenafil—ABCC10—Methotrexate—breast cancer	0.0174	0.0375	CbGbCtD
Sildenafil—ABCC4—Fluorouracil—breast cancer	0.0152	0.0327	CbGbCtD
Sildenafil—CYP2C9—Anastrozole—breast cancer	0.0123	0.0265	CbGbCtD
Sildenafil—CYP3A5—Lapatinib—breast cancer	0.0123	0.0264	CbGbCtD
Sildenafil—CYP1A1—Tamoxifen—breast cancer	0.0102	0.022	CbGbCtD
Sildenafil—CYP2C19—Lapatinib—breast cancer	0.00989	0.0213	CbGbCtD
Sildenafil—CYP3A4—Exemestane—breast cancer	0.00945	0.0203	CbGbCtD
Sildenafil—CYP2C9—Idarubicin—breast cancer	0.00934	0.0201	CbGbCtD
Sildenafil—CYP2D6—Idarubicin—breast cancer	0.00854	0.0184	CbGbCtD
Sildenafil—ABCC4—Methotrexate—breast cancer	0.00837	0.018	CbGbCtD
Sildenafil—CYP3A7—Tamoxifen—breast cancer	0.00818	0.0176	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00818	0.0176	CbGbCtD
Sildenafil—CYP3A4—Letrozole—breast cancer	0.00804	0.0173	CbGbCtD
Sildenafil—CYP2E1—Tamoxifen—breast cancer	0.0079	0.017	CbGbCtD
Sildenafil—CYP2E1—Mitoxantrone—breast cancer	0.0077	0.0166	CbGbCtD
Sildenafil—CYP3A4—Anastrozole—breast cancer	0.00716	0.0154	CbGbCtD
Sildenafil—CYP3A4—Toremifene—breast cancer	0.00655	0.0141	CbGbCtD
Sildenafil—CYP3A7—Paclitaxel—breast cancer	0.00637	0.0137	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00637	0.0137	CbGbCtD
Sildenafil—CYP3A7—Irinotecan—breast cancer	0.00628	0.0135	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00628	0.0135	CbGbCtD
Sildenafil—CYP3A5—Tamoxifen—breast cancer	0.00614	0.0132	CbGbCtD
Sildenafil—CYP3A4—Fulvestrant—breast cancer	0.00609	0.0131	CbGbCtD
Sildenafil—CYP3A4—Thiotepa—breast cancer	0.00543	0.0117	CbGbCtD
Sildenafil—CYP2C9—Capecitabine—breast cancer	0.00512	0.011	CbGbCtD
Sildenafil—CYP3A4—Ixabepilone—breast cancer	0.00497	0.0107	CbGbCtD
Sildenafil—CYP2C19—Tamoxifen—breast cancer	0.00495	0.0107	CbGbCtD
Sildenafil—CYP3A4—Lapatinib—breast cancer	0.00478	0.0103	CbGbCtD
Sildenafil—CYP3A5—Paclitaxel—breast cancer	0.00478	0.0103	CbGbCtD
Sildenafil—CYP3A5—Irinotecan—breast cancer	0.00471	0.0101	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.0046	0.00991	CbGbCtD
Sildenafil—CYP3A7—Docetaxel—breast cancer	0.0046	0.00991	CbGbCtD
Sildenafil—CYP2D6—Vinorelbine—breast cancer	0.00417	0.00897	CbGbCtD
Sildenafil—CYP2C9—Tamoxifen—breast cancer	0.00412	0.00885	CbGbCtD
Sildenafil—CYP2D6—Tamoxifen—breast cancer	0.00376	0.0081	CbGbCtD
Sildenafil—CYP3A4—Raloxifene—breast cancer	0.00362	0.00779	CbGbCtD
Sildenafil—CYP3A5—Docetaxel—breast cancer	0.00345	0.00743	CbGbCtD
Sildenafil—CYP2C9—Paclitaxel—breast cancer	0.0032	0.00689	CbGbCtD
Sildenafil—CYP2C9—Fluorouracil—breast cancer	0.00303	0.00653	CbGbCtD
Sildenafil—CYP3A4—Vinorelbine—breast cancer	0.00265	0.0057	CbGbCtD
Sildenafil—CYP2D6—Vinblastine—breast cancer	0.00257	0.00553	CbGbCtD
Sildenafil—CYP3A4—Tamoxifen—breast cancer	0.00239	0.00515	CbGbCtD
Sildenafil—CYP3A4—Mitoxantrone—breast cancer	0.00233	0.00502	CbGbCtD
Sildenafil—CYP3A4—Paclitaxel—breast cancer	0.00186	0.00401	CbGbCtD
Sildenafil—CYP3A4—Irinotecan—breast cancer	0.00184	0.00395	CbGbCtD
Sildenafil—CYP3A4—Vinblastine—breast cancer	0.00163	0.00352	CbGbCtD
Sildenafil—CYP2D6—Doxorubicin—breast cancer	0.00158	0.0034	CbGbCtD
Sildenafil—CYP3A4—Docetaxel—breast cancer	0.00135	0.0029	CbGbCtD
Sildenafil—PDE6G—adrenal gland—breast cancer	0.00117	0.0511	CbGeAlD
Sildenafil—PDE6H—endocrine gland—breast cancer	0.00106	0.0461	CbGeAlD
Sildenafil—ABCC5—mammary gland—breast cancer	0.00105	0.0458	CbGeAlD
Sildenafil—CYP3A4—Doxorubicin—breast cancer	0.001	0.00216	CbGbCtD
Sildenafil—ABCC10—nipple—breast cancer	0.000727	0.0317	CbGeAlD
Sildenafil—PDE6G—lymph node—breast cancer	0.000704	0.0307	CbGeAlD
Sildenafil—PDE5A—epithelium—breast cancer	0.00064	0.0279	CbGeAlD
Sildenafil—Udenafil—CYP3A4—breast cancer	0.000635	0.597	CrCbGaD
Sildenafil—ADORA2A—female reproductive system—breast cancer	0.000522	0.0227	CbGeAlD
Sildenafil—PDE5A—adipose tissue—breast cancer	0.000518	0.0225	CbGeAlD
Sildenafil—ADORA2A—adrenal gland—breast cancer	0.00051	0.0222	CbGeAlD
Sildenafil—PDE5A—female reproductive system—breast cancer	0.000476	0.0207	CbGeAlD
Sildenafil—ABCC5—pituitary gland—breast cancer	0.000475	0.0207	CbGeAlD
Sildenafil—CYP3A7—endocrine gland—breast cancer	0.000475	0.0207	CbGeAlD
Sildenafil—ABCC5—adipose tissue—breast cancer	0.000473	0.0206	CbGeAlD
Sildenafil—CYP2C9—mammary gland—breast cancer	0.00047	0.0205	CbGeAlD
Sildenafil—PDE5A—adrenal gland—breast cancer	0.000464	0.0202	CbGeAlD
Sildenafil—ADORA2A—endocrine gland—breast cancer	0.000442	0.0192	CbGeAlD
Sildenafil—ABCC10—endometrium—breast cancer	0.000439	0.0191	CbGeAlD
Sildenafil—PDE5A—female gonad—breast cancer	0.000433	0.0188	CbGeAlD
Sildenafil—Vardenafil—CYP3A4—breast cancer	0.000429	0.403	CrCbGaD
Sildenafil—ABCC5—adrenal gland—breast cancer	0.000425	0.0185	CbGeAlD
Sildenafil—ABCC5—bone marrow—breast cancer	0.000411	0.0179	CbGeAlD
Sildenafil—ABCC10—uterus—breast cancer	0.000404	0.0176	CbGeAlD
Sildenafil—CYP1A1—nipple—breast cancer	0.000404	0.0176	CbGeAlD
Sildenafil—PDE5A—endocrine gland—breast cancer	0.000403	0.0175	CbGeAlD
Sildenafil—ABCC10—pituitary gland—breast cancer	0.000397	0.0173	CbGeAlD
Sildenafil—ABCC5—female gonad—breast cancer	0.000396	0.0172	CbGeAlD
Sildenafil—ABCC10—adipose tissue—breast cancer	0.000396	0.0172	CbGeAlD
Sildenafil—ABCC10—female reproductive system—breast cancer	0.000364	0.0158	CbGeAlD
Sildenafil—ABCC10—adrenal gland—breast cancer	0.000355	0.0154	CbGeAlD
Sildenafil—ABCC10—bone marrow—breast cancer	0.000343	0.0149	CbGeAlD
Sildenafil—ABCC4—uterus—breast cancer	0.000336	0.0146	CbGeAlD
Sildenafil—ABCC10—female gonad—breast cancer	0.000331	0.0144	CbGeAlD
Sildenafil—ABCC4—adipose tissue—breast cancer	0.000328	0.0143	CbGeAlD
Sildenafil—ABCC10—endocrine gland—breast cancer	0.000308	0.0134	CbGeAlD
Sildenafil—ABCC4—female reproductive system—breast cancer	0.000302	0.0131	CbGeAlD
Sildenafil—ABCC4—adrenal gland—breast cancer	0.000294	0.0128	CbGeAlD
Sildenafil—ABCC4—bone marrow—breast cancer	0.000285	0.0124	CbGeAlD
Sildenafil—PDE5A—lymph node—breast cancer	0.000278	0.0121	CbGeAlD
Sildenafil—ABCC4—female gonad—breast cancer	0.000274	0.0119	CbGeAlD
Sildenafil—CYP1A1—epithelium—breast cancer	0.000272	0.0118	CbGeAlD
Sildenafil—CYP1A1—skin of body—breast cancer	0.000259	0.0113	CbGeAlD
Sildenafil—ABCC4—endocrine gland—breast cancer	0.000255	0.0111	CbGeAlD
Sildenafil—ABCC5—lymph node—breast cancer	0.000255	0.0111	CbGeAlD
Sildenafil—CYP1A1—uterus—breast cancer	0.000225	0.00979	CbGeAlD
Sildenafil—CYP1A1—adipose tissue—breast cancer	0.00022	0.00957	CbGeAlD
Sildenafil—CYP3A5—adipose tissue—breast cancer	0.000215	0.00936	CbGeAlD
Sildenafil—ABCC10—lymph node—breast cancer	0.000213	0.00926	CbGeAlD
Sildenafil—CYP2C19—endocrine gland—breast cancer	0.000212	0.00924	CbGeAlD
Sildenafil—CYP1A1—female reproductive system—breast cancer	0.000202	0.0088	CbGeAlD
Sildenafil—CYP2C9—female reproductive system—breast cancer	0.000195	0.00847	CbGeAlD
Sildenafil—CYP2E1—female reproductive system—breast cancer	0.000184	0.00803	CbGeAlD
Sildenafil—CYP1A1—female gonad—breast cancer	0.000184	0.00801	CbGeAlD
Sildenafil—CYP2E1—adrenal gland—breast cancer	0.00018	0.00783	CbGeAlD
Sildenafil—CYP3A5—female gonad—breast cancer	0.00018	0.00783	CbGeAlD
Sildenafil—ABCC4—lymph node—breast cancer	0.000176	0.00768	CbGeAlD
Sildenafil—CYP1A1—endocrine gland—breast cancer	0.000171	0.00745	CbGeAlD
Sildenafil—CYP3A5—endocrine gland—breast cancer	0.000167	0.00728	CbGeAlD
Sildenafil—CYP2C9—endocrine gland—breast cancer	0.000165	0.00717	CbGeAlD
Sildenafil—CYP2E1—endocrine gland—breast cancer	0.000156	0.00679	CbGeAlD
Sildenafil—CYP3A4—female reproductive system—breast cancer	0.000148	0.00646	CbGeAlD
Sildenafil—CYP2D6—female reproductive system—breast cancer	0.000146	0.00635	CbGeAlD
Sildenafil—CYP2D6—female gonad—breast cancer	0.000133	0.00578	CbGeAlD
Sildenafil—CYP3A4—endocrine gland—breast cancer	0.000126	0.00546	CbGeAlD
Sildenafil—CYP2D6—endocrine gland—breast cancer	0.000124	0.00538	CbGeAlD
Sildenafil—CYP1A1—lymph node—breast cancer	0.000118	0.00515	CbGeAlD
Sildenafil—Dermatitis—Fluorouracil—breast cancer	1.99e-05	0.000114	CcSEcCtD
Sildenafil—Pharyngitis—Doxorubicin—breast cancer	1.99e-05	0.000114	CcSEcCtD
Sildenafil—Paraesthesia—Capecitabine—breast cancer	1.98e-05	0.000114	CcSEcCtD
Sildenafil—Decreased appetite—Docetaxel—breast cancer	1.98e-05	0.000114	CcSEcCtD
Sildenafil—Hypersensitivity—Paclitaxel—breast cancer	1.98e-05	0.000114	CcSEcCtD
Sildenafil—Headache—Fluorouracil—breast cancer	1.98e-05	0.000114	CcSEcCtD
Sildenafil—Urinary tract disorder—Doxorubicin—breast cancer	1.98e-05	0.000114	CcSEcCtD
Sildenafil—Oedema peripheral—Doxorubicin—breast cancer	1.97e-05	0.000114	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Docetaxel—breast cancer	1.97e-05	0.000113	CcSEcCtD
Sildenafil—Connective tissue disorder—Doxorubicin—breast cancer	1.97e-05	0.000113	CcSEcCtD
Sildenafil—Dyspnoea—Capecitabine—breast cancer	1.97e-05	0.000113	CcSEcCtD
Sildenafil—Fatigue—Docetaxel—breast cancer	1.96e-05	0.000113	CcSEcCtD
Sildenafil—Angiopathy—Epirubicin—breast cancer	1.96e-05	0.000113	CcSEcCtD
Sildenafil—Urethral disorder—Doxorubicin—breast cancer	1.96e-05	0.000113	CcSEcCtD
Sildenafil—Nausea—Mitoxantrone—breast cancer	1.96e-05	0.000113	CcSEcCtD
Sildenafil—Nausea—Irinotecan—breast cancer	1.96e-05	0.000113	CcSEcCtD
Sildenafil—Immune system disorder—Epirubicin—breast cancer	1.95e-05	0.000112	CcSEcCtD
Sildenafil—Mediastinal disorder—Epirubicin—breast cancer	1.95e-05	0.000112	CcSEcCtD
Sildenafil—Constipation—Docetaxel—breast cancer	1.95e-05	0.000112	CcSEcCtD
Sildenafil—Pain—Docetaxel—breast cancer	1.95e-05	0.000112	CcSEcCtD
Sildenafil—Back pain—Methotrexate—breast cancer	1.95e-05	0.000112	CcSEcCtD
Sildenafil—Dyspepsia—Capecitabine—breast cancer	1.94e-05	0.000112	CcSEcCtD
Sildenafil—Chills—Epirubicin—breast cancer	1.94e-05	0.000112	CcSEcCtD
Sildenafil—Arrhythmia—Epirubicin—breast cancer	1.93e-05	0.000111	CcSEcCtD
Sildenafil—Visual impairment—Doxorubicin—breast cancer	1.93e-05	0.000111	CcSEcCtD
Sildenafil—Asthenia—Paclitaxel—breast cancer	1.93e-05	0.000111	CcSEcCtD
Sildenafil—Decreased appetite—Capecitabine—breast cancer	1.92e-05	0.00011	CcSEcCtD
Sildenafil—Alopecia—Epirubicin—breast cancer	1.91e-05	0.00011	CcSEcCtD
Sildenafil—Nausea—Gemcitabine—breast cancer	1.91e-05	0.00011	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Capecitabine—breast cancer	1.9e-05	0.00011	CcSEcCtD
Sildenafil—Fatigue—Capecitabine—breast cancer	1.9e-05	0.00011	CcSEcCtD
Sildenafil—Pruritus—Paclitaxel—breast cancer	1.9e-05	0.000109	CcSEcCtD
Sildenafil—Vision blurred—Methotrexate—breast cancer	1.9e-05	0.000109	CcSEcCtD
Sildenafil—Mental disorder—Epirubicin—breast cancer	1.9e-05	0.000109	CcSEcCtD
Sildenafil—Erythema multiforme—Doxorubicin—breast cancer	1.89e-05	0.000109	CcSEcCtD
Sildenafil—Pain—Capecitabine—breast cancer	1.89e-05	0.000109	CcSEcCtD
Sildenafil—Constipation—Capecitabine—breast cancer	1.89e-05	0.000109	CcSEcCtD
Sildenafil—Erythema—Epirubicin—breast cancer	1.88e-05	0.000108	CcSEcCtD
Sildenafil—Malnutrition—Epirubicin—breast cancer	1.88e-05	0.000108	CcSEcCtD
Sildenafil—Feeling abnormal—Docetaxel—breast cancer	1.88e-05	0.000108	CcSEcCtD
Sildenafil—Nausea—Fluorouracil—breast cancer	1.88e-05	0.000108	CcSEcCtD
Sildenafil—Eye disorder—Doxorubicin—breast cancer	1.87e-05	0.000108	CcSEcCtD
Sildenafil—Ill-defined disorder—Methotrexate—breast cancer	1.87e-05	0.000107	CcSEcCtD
Sildenafil—Tinnitus—Doxorubicin—breast cancer	1.87e-05	0.000107	CcSEcCtD
Sildenafil—Gastrointestinal pain—Docetaxel—breast cancer	1.86e-05	0.000107	CcSEcCtD
Sildenafil—Anaemia—Methotrexate—breast cancer	1.86e-05	0.000107	CcSEcCtD
Sildenafil—Flushing—Doxorubicin—breast cancer	1.86e-05	0.000107	CcSEcCtD
Sildenafil—Cardiac disorder—Doxorubicin—breast cancer	1.86e-05	0.000107	CcSEcCtD
Sildenafil—Flatulence—Epirubicin—breast cancer	1.86e-05	0.000107	CcSEcCtD
Sildenafil—Tension—Epirubicin—breast cancer	1.85e-05	0.000106	CcSEcCtD
Sildenafil—Diarrhoea—Paclitaxel—breast cancer	1.84e-05	0.000106	CcSEcCtD
Sildenafil—Nervousness—Epirubicin—breast cancer	1.83e-05	0.000105	CcSEcCtD
Sildenafil—Back pain—Epirubicin—breast cancer	1.82e-05	0.000105	CcSEcCtD
Sildenafil—Feeling abnormal—Capecitabine—breast cancer	1.82e-05	0.000105	CcSEcCtD
Sildenafil—Angiopathy—Doxorubicin—breast cancer	1.82e-05	0.000105	CcSEcCtD
Sildenafil—Malaise—Methotrexate—breast cancer	1.81e-05	0.000104	CcSEcCtD
Sildenafil—Immune system disorder—Doxorubicin—breast cancer	1.81e-05	0.000104	CcSEcCtD
Sildenafil—Vertigo—Methotrexate—breast cancer	1.81e-05	0.000104	CcSEcCtD
Sildenafil—Gastrointestinal pain—Capecitabine—breast cancer	1.8e-05	0.000104	CcSEcCtD
Sildenafil—Mediastinal disorder—Doxorubicin—breast cancer	1.8e-05	0.000104	CcSEcCtD
Sildenafil—Body temperature increased—Docetaxel—breast cancer	1.8e-05	0.000104	CcSEcCtD
Sildenafil—Abdominal pain—Docetaxel—breast cancer	1.8e-05	0.000104	CcSEcCtD
Sildenafil—Leukopenia—Methotrexate—breast cancer	1.8e-05	0.000104	CcSEcCtD
Sildenafil—Chills—Doxorubicin—breast cancer	1.8e-05	0.000103	CcSEcCtD
Sildenafil—Arrhythmia—Doxorubicin—breast cancer	1.79e-05	0.000103	CcSEcCtD
Sildenafil—Dizziness—Paclitaxel—breast cancer	1.78e-05	0.000102	CcSEcCtD
Sildenafil—Vision blurred—Epirubicin—breast cancer	1.78e-05	0.000102	CcSEcCtD
Sildenafil—Alopecia—Doxorubicin—breast cancer	1.77e-05	0.000102	CcSEcCtD
Sildenafil—Cough—Methotrexate—breast cancer	1.76e-05	0.000101	CcSEcCtD
Sildenafil—Mental disorder—Doxorubicin—breast cancer	1.75e-05	0.000101	CcSEcCtD
Sildenafil—Urticaria—Capecitabine—breast cancer	1.75e-05	0.000101	CcSEcCtD
Sildenafil—Ill-defined disorder—Epirubicin—breast cancer	1.75e-05	0.000101	CcSEcCtD
Sildenafil—Abdominal pain—Capecitabine—breast cancer	1.74e-05	0.0001	CcSEcCtD
Sildenafil—Body temperature increased—Capecitabine—breast cancer	1.74e-05	0.0001	CcSEcCtD
Sildenafil—Convulsion—Methotrexate—breast cancer	1.74e-05	0.0001	CcSEcCtD
Sildenafil—Erythema—Doxorubicin—breast cancer	1.74e-05	0.0001	CcSEcCtD
Sildenafil—Malnutrition—Doxorubicin—breast cancer	1.74e-05	0.0001	CcSEcCtD
Sildenafil—Anaemia—Epirubicin—breast cancer	1.74e-05	0.0001	CcSEcCtD
Sildenafil—Agitation—Epirubicin—breast cancer	1.73e-05	9.96e-05	CcSEcCtD
Sildenafil—Flatulence—Doxorubicin—breast cancer	1.72e-05	9.88e-05	CcSEcCtD
Sildenafil—Chest pain—Methotrexate—breast cancer	1.71e-05	9.86e-05	CcSEcCtD
Sildenafil—Myalgia—Methotrexate—breast cancer	1.71e-05	9.86e-05	CcSEcCtD
Sildenafil—Arthralgia—Methotrexate—breast cancer	1.71e-05	9.86e-05	CcSEcCtD
Sildenafil—Tension—Doxorubicin—breast cancer	1.71e-05	9.84e-05	CcSEcCtD
Sildenafil—Vomiting—Paclitaxel—breast cancer	1.71e-05	9.84e-05	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.7e-05	9.8e-05	CcSEcCtD
Sildenafil—Malaise—Epirubicin—breast cancer	1.7e-05	9.78e-05	CcSEcCtD
Sildenafil—Rash—Paclitaxel—breast cancer	1.7e-05	9.76e-05	CcSEcCtD
Sildenafil—Dermatitis—Paclitaxel—breast cancer	1.69e-05	9.75e-05	CcSEcCtD
Sildenafil—Discomfort—Methotrexate—breast cancer	1.69e-05	9.74e-05	CcSEcCtD
Sildenafil—Nervousness—Doxorubicin—breast cancer	1.69e-05	9.74e-05	CcSEcCtD
Sildenafil—Vertigo—Epirubicin—breast cancer	1.69e-05	9.74e-05	CcSEcCtD
Sildenafil—Syncope—Epirubicin—breast cancer	1.69e-05	9.72e-05	CcSEcCtD
Sildenafil—Leukopenia—Epirubicin—breast cancer	1.69e-05	9.7e-05	CcSEcCtD
Sildenafil—Back pain—Doxorubicin—breast cancer	1.69e-05	9.7e-05	CcSEcCtD
Sildenafil—Headache—Paclitaxel—breast cancer	1.68e-05	9.7e-05	CcSEcCtD
Sildenafil—Hypersensitivity—Docetaxel—breast cancer	1.68e-05	9.67e-05	CcSEcCtD
Sildenafil—Palpitations—Epirubicin—breast cancer	1.66e-05	9.58e-05	CcSEcCtD
Sildenafil—Loss of consciousness—Epirubicin—breast cancer	1.66e-05	9.53e-05	CcSEcCtD
Sildenafil—Cough—Epirubicin—breast cancer	1.64e-05	9.46e-05	CcSEcCtD
Sildenafil—Vision blurred—Doxorubicin—breast cancer	1.64e-05	9.45e-05	CcSEcCtD
Sildenafil—Asthenia—Docetaxel—breast cancer	1.64e-05	9.41e-05	CcSEcCtD
Sildenafil—Convulsion—Epirubicin—breast cancer	1.63e-05	9.39e-05	CcSEcCtD
Sildenafil—Infection—Methotrexate—breast cancer	1.63e-05	9.39e-05	CcSEcCtD
Sildenafil—Hypertension—Epirubicin—breast cancer	1.63e-05	9.36e-05	CcSEcCtD
Sildenafil—Hypersensitivity—Capecitabine—breast cancer	1.63e-05	9.36e-05	CcSEcCtD
Sildenafil—Ill-defined disorder—Doxorubicin—breast cancer	1.62e-05	9.31e-05	CcSEcCtD
Sildenafil—Pruritus—Docetaxel—breast cancer	1.61e-05	9.28e-05	CcSEcCtD
Sildenafil—Nervous system disorder—Methotrexate—breast cancer	1.61e-05	9.27e-05	CcSEcCtD
Sildenafil—Anaemia—Doxorubicin—breast cancer	1.61e-05	9.27e-05	CcSEcCtD
Sildenafil—Chest pain—Epirubicin—breast cancer	1.6e-05	9.23e-05	CcSEcCtD
Sildenafil—Myalgia—Epirubicin—breast cancer	1.6e-05	9.23e-05	CcSEcCtD
Sildenafil—Arthralgia—Epirubicin—breast cancer	1.6e-05	9.23e-05	CcSEcCtD
Sildenafil—Agitation—Doxorubicin—breast cancer	1.6e-05	9.22e-05	CcSEcCtD
Sildenafil—Anxiety—Epirubicin—breast cancer	1.6e-05	9.2e-05	CcSEcCtD
Sildenafil—Nausea—Paclitaxel—breast cancer	1.6e-05	9.19e-05	CcSEcCtD
Sildenafil—Skin disorder—Methotrexate—breast cancer	1.6e-05	9.18e-05	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.59e-05	9.17e-05	CcSEcCtD
Sildenafil—Hyperhidrosis—Methotrexate—breast cancer	1.59e-05	9.14e-05	CcSEcCtD
Sildenafil—Discomfort—Epirubicin—breast cancer	1.58e-05	9.12e-05	CcSEcCtD
Sildenafil—Asthenia—Capecitabine—breast cancer	1.58e-05	9.11e-05	CcSEcCtD
Sildenafil—Malaise—Doxorubicin—breast cancer	1.57e-05	9.05e-05	CcSEcCtD
Sildenafil—Dry mouth—Epirubicin—breast cancer	1.57e-05	9.03e-05	CcSEcCtD
Sildenafil—Vertigo—Doxorubicin—breast cancer	1.57e-05	9.01e-05	CcSEcCtD
Sildenafil—Anorexia—Methotrexate—breast cancer	1.57e-05	9.01e-05	CcSEcCtD
Sildenafil—Syncope—Doxorubicin—breast cancer	1.56e-05	9e-05	CcSEcCtD
Sildenafil—Pruritus—Capecitabine—breast cancer	1.56e-05	8.99e-05	CcSEcCtD
Sildenafil—Leukopenia—Doxorubicin—breast cancer	1.56e-05	8.98e-05	CcSEcCtD
Sildenafil—Diarrhoea—Docetaxel—breast cancer	1.56e-05	8.98e-05	CcSEcCtD
Sildenafil—Palpitations—Doxorubicin—breast cancer	1.54e-05	8.86e-05	CcSEcCtD
Sildenafil—Oedema—Epirubicin—breast cancer	1.54e-05	8.85e-05	CcSEcCtD
Sildenafil—Hypotension—Methotrexate—breast cancer	1.53e-05	8.83e-05	CcSEcCtD
Sildenafil—Loss of consciousness—Doxorubicin—breast cancer	1.53e-05	8.82e-05	CcSEcCtD
Sildenafil—Infection—Epirubicin—breast cancer	1.53e-05	8.79e-05	CcSEcCtD
Sildenafil—Cough—Doxorubicin—breast cancer	1.52e-05	8.75e-05	CcSEcCtD
Sildenafil—Shock—Epirubicin—breast cancer	1.51e-05	8.71e-05	CcSEcCtD
Sildenafil—Convulsion—Doxorubicin—breast cancer	1.51e-05	8.69e-05	CcSEcCtD
Sildenafil—Diarrhoea—Capecitabine—breast cancer	1.51e-05	8.69e-05	CcSEcCtD
Sildenafil—Nervous system disorder—Epirubicin—breast cancer	1.51e-05	8.68e-05	CcSEcCtD
Sildenafil—Dizziness—Docetaxel—breast cancer	1.51e-05	8.67e-05	CcSEcCtD
Sildenafil—Hypertension—Doxorubicin—breast cancer	1.5e-05	8.66e-05	CcSEcCtD
Sildenafil—Tachycardia—Epirubicin—breast cancer	1.5e-05	8.64e-05	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Methotrexate—breast cancer	1.5e-05	8.61e-05	CcSEcCtD
Sildenafil—Skin disorder—Epirubicin—breast cancer	1.49e-05	8.59e-05	CcSEcCtD
Sildenafil—Hyperhidrosis—Epirubicin—breast cancer	1.49e-05	8.55e-05	CcSEcCtD
Sildenafil—Insomnia—Methotrexate—breast cancer	1.49e-05	8.55e-05	CcSEcCtD
Sildenafil—Chest pain—Doxorubicin—breast cancer	1.48e-05	8.54e-05	CcSEcCtD
Sildenafil—Myalgia—Doxorubicin—breast cancer	1.48e-05	8.54e-05	CcSEcCtD
Sildenafil—Arthralgia—Doxorubicin—breast cancer	1.48e-05	8.54e-05	CcSEcCtD
Sildenafil—Anxiety—Doxorubicin—breast cancer	1.48e-05	8.51e-05	CcSEcCtD
Sildenafil—Paraesthesia—Methotrexate—breast cancer	1.47e-05	8.49e-05	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.47e-05	8.48e-05	CcSEcCtD
Sildenafil—Discomfort—Doxorubicin—breast cancer	1.47e-05	8.44e-05	CcSEcCtD
Sildenafil—Anorexia—Epirubicin—breast cancer	1.47e-05	8.43e-05	CcSEcCtD
Sildenafil—Dyspnoea—Methotrexate—breast cancer	1.46e-05	8.43e-05	CcSEcCtD
Sildenafil—Somnolence—Methotrexate—breast cancer	1.46e-05	8.41e-05	CcSEcCtD
Sildenafil—Dizziness—Capecitabine—breast cancer	1.46e-05	8.4e-05	CcSEcCtD
Sildenafil—Dry mouth—Doxorubicin—breast cancer	1.45e-05	8.35e-05	CcSEcCtD
Sildenafil—Vomiting—Docetaxel—breast cancer	1.45e-05	8.34e-05	CcSEcCtD
Sildenafil—Dyspepsia—Methotrexate—breast cancer	1.45e-05	8.32e-05	CcSEcCtD
Sildenafil—Rash—Docetaxel—breast cancer	1.44e-05	8.27e-05	CcSEcCtD
Sildenafil—Hypotension—Epirubicin—breast cancer	1.44e-05	8.27e-05	CcSEcCtD
Sildenafil—Dermatitis—Docetaxel—breast cancer	1.44e-05	8.26e-05	CcSEcCtD
Sildenafil—Decreased appetite—Methotrexate—breast cancer	1.43e-05	8.22e-05	CcSEcCtD
Sildenafil—Headache—Docetaxel—breast cancer	1.43e-05	8.22e-05	CcSEcCtD
Sildenafil—Oedema—Doxorubicin—breast cancer	1.42e-05	8.19e-05	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Methotrexate—breast cancer	1.42e-05	8.16e-05	CcSEcCtD
Sildenafil—Fatigue—Methotrexate—breast cancer	1.42e-05	8.15e-05	CcSEcCtD
Sildenafil—Infection—Doxorubicin—breast cancer	1.41e-05	8.13e-05	CcSEcCtD
Sildenafil—Pain—Methotrexate—breast cancer	1.4e-05	8.09e-05	CcSEcCtD
Sildenafil—Vomiting—Capecitabine—breast cancer	1.4e-05	8.08e-05	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Epirubicin—breast cancer	1.4e-05	8.06e-05	CcSEcCtD
Sildenafil—Shock—Doxorubicin—breast cancer	1.4e-05	8.05e-05	CcSEcCtD
Sildenafil—Nervous system disorder—Doxorubicin—breast cancer	1.39e-05	8.03e-05	CcSEcCtD
Sildenafil—Rash—Capecitabine—breast cancer	1.39e-05	8.01e-05	CcSEcCtD
Sildenafil—Insomnia—Epirubicin—breast cancer	1.39e-05	8e-05	CcSEcCtD
Sildenafil—Dermatitis—Capecitabine—breast cancer	1.39e-05	8e-05	CcSEcCtD
Sildenafil—Tachycardia—Doxorubicin—breast cancer	1.39e-05	7.99e-05	CcSEcCtD
Sildenafil—Headache—Capecitabine—breast cancer	1.38e-05	7.96e-05	CcSEcCtD
Sildenafil—Skin disorder—Doxorubicin—breast cancer	1.38e-05	7.95e-05	CcSEcCtD
Sildenafil—Paraesthesia—Epirubicin—breast cancer	1.38e-05	7.95e-05	CcSEcCtD
Sildenafil—Hyperhidrosis—Doxorubicin—breast cancer	1.37e-05	7.91e-05	CcSEcCtD
Sildenafil—Dyspnoea—Epirubicin—breast cancer	1.37e-05	7.89e-05	CcSEcCtD
Sildenafil—Somnolence—Epirubicin—breast cancer	1.37e-05	7.87e-05	CcSEcCtD
Sildenafil—Anorexia—Doxorubicin—breast cancer	1.36e-05	7.8e-05	CcSEcCtD
Sildenafil—Nausea—Docetaxel—breast cancer	1.35e-05	7.79e-05	CcSEcCtD
Sildenafil—Feeling abnormal—Methotrexate—breast cancer	1.35e-05	7.79e-05	CcSEcCtD
Sildenafil—Dyspepsia—Epirubicin—breast cancer	1.35e-05	7.79e-05	CcSEcCtD
Sildenafil—Gastrointestinal pain—Methotrexate—breast cancer	1.34e-05	7.73e-05	CcSEcCtD
Sildenafil—Decreased appetite—Epirubicin—breast cancer	1.34e-05	7.69e-05	CcSEcCtD
Sildenafil—Hypotension—Doxorubicin—breast cancer	1.33e-05	7.65e-05	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Epirubicin—breast cancer	1.33e-05	7.64e-05	CcSEcCtD
Sildenafil—Fatigue—Epirubicin—breast cancer	1.33e-05	7.63e-05	CcSEcCtD
Sildenafil—Pain—Epirubicin—breast cancer	1.31e-05	7.57e-05	CcSEcCtD
Sildenafil—Constipation—Epirubicin—breast cancer	1.31e-05	7.57e-05	CcSEcCtD
Sildenafil—Nausea—Capecitabine—breast cancer	1.31e-05	7.54e-05	CcSEcCtD
Sildenafil—Urticaria—Methotrexate—breast cancer	1.3e-05	7.51e-05	CcSEcCtD
Sildenafil—Abdominal pain—Methotrexate—breast cancer	1.3e-05	7.47e-05	CcSEcCtD
Sildenafil—Body temperature increased—Methotrexate—breast cancer	1.3e-05	7.47e-05	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.3e-05	7.46e-05	CcSEcCtD
Sildenafil—Insomnia—Doxorubicin—breast cancer	1.29e-05	7.4e-05	CcSEcCtD
Sildenafil—Paraesthesia—Doxorubicin—breast cancer	1.28e-05	7.35e-05	CcSEcCtD
Sildenafil—Dyspnoea—Doxorubicin—breast cancer	1.27e-05	7.3e-05	CcSEcCtD
Sildenafil—Feeling abnormal—Epirubicin—breast cancer	1.27e-05	7.29e-05	CcSEcCtD
Sildenafil—Somnolence—Doxorubicin—breast cancer	1.26e-05	7.28e-05	CcSEcCtD
Sildenafil—Gastrointestinal pain—Epirubicin—breast cancer	1.26e-05	7.24e-05	CcSEcCtD
Sildenafil—Dyspepsia—Doxorubicin—breast cancer	1.25e-05	7.21e-05	CcSEcCtD
Sildenafil—Decreased appetite—Doxorubicin—breast cancer	1.24e-05	7.12e-05	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Doxorubicin—breast cancer	1.23e-05	7.07e-05	CcSEcCtD
Sildenafil—Fatigue—Doxorubicin—breast cancer	1.23e-05	7.06e-05	CcSEcCtD
Sildenafil—Urticaria—Epirubicin—breast cancer	1.22e-05	7.03e-05	CcSEcCtD
Sildenafil—Constipation—Doxorubicin—breast cancer	1.22e-05	7e-05	CcSEcCtD
Sildenafil—Pain—Doxorubicin—breast cancer	1.22e-05	7e-05	CcSEcCtD
Sildenafil—Abdominal pain—Epirubicin—breast cancer	1.22e-05	6.99e-05	CcSEcCtD
Sildenafil—Body temperature increased—Epirubicin—breast cancer	1.22e-05	6.99e-05	CcSEcCtD
Sildenafil—Hypersensitivity—Methotrexate—breast cancer	1.21e-05	6.97e-05	CcSEcCtD
Sildenafil—Asthenia—Methotrexate—breast cancer	1.18e-05	6.78e-05	CcSEcCtD
Sildenafil—Feeling abnormal—Doxorubicin—breast cancer	1.17e-05	6.75e-05	CcSEcCtD
Sildenafil—Gastrointestinal pain—Doxorubicin—breast cancer	1.16e-05	6.69e-05	CcSEcCtD
Sildenafil—Pruritus—Methotrexate—breast cancer	1.16e-05	6.69e-05	CcSEcCtD
Sildenafil—Hypersensitivity—Epirubicin—breast cancer	1.13e-05	6.52e-05	CcSEcCtD
Sildenafil—Urticaria—Doxorubicin—breast cancer	1.13e-05	6.5e-05	CcSEcCtD
Sildenafil—Abdominal pain—Doxorubicin—breast cancer	1.12e-05	6.47e-05	CcSEcCtD
Sildenafil—Body temperature increased—Doxorubicin—breast cancer	1.12e-05	6.47e-05	CcSEcCtD
Sildenafil—Diarrhoea—Methotrexate—breast cancer	1.12e-05	6.47e-05	CcSEcCtD
Sildenafil—Asthenia—Epirubicin—breast cancer	1.1e-05	6.35e-05	CcSEcCtD
Sildenafil—Pruritus—Epirubicin—breast cancer	1.09e-05	6.26e-05	CcSEcCtD
Sildenafil—Dizziness—Methotrexate—breast cancer	1.09e-05	6.25e-05	CcSEcCtD
Sildenafil—Diarrhoea—Epirubicin—breast cancer	1.05e-05	6.05e-05	CcSEcCtD
Sildenafil—Hypersensitivity—Doxorubicin—breast cancer	1.05e-05	6.03e-05	CcSEcCtD
Sildenafil—Vomiting—Methotrexate—breast cancer	1.04e-05	6.01e-05	CcSEcCtD
Sildenafil—Rash—Methotrexate—breast cancer	1.04e-05	5.96e-05	CcSEcCtD
Sildenafil—Dermatitis—Methotrexate—breast cancer	1.03e-05	5.96e-05	CcSEcCtD
Sildenafil—Headache—Methotrexate—breast cancer	1.03e-05	5.92e-05	CcSEcCtD
Sildenafil—Asthenia—Doxorubicin—breast cancer	1.02e-05	5.87e-05	CcSEcCtD
Sildenafil—Dizziness—Epirubicin—breast cancer	1.02e-05	5.85e-05	CcSEcCtD
Sildenafil—Pruritus—Doxorubicin—breast cancer	1.01e-05	5.79e-05	CcSEcCtD
Sildenafil—Vomiting—Epirubicin—breast cancer	9.77e-06	5.63e-05	CcSEcCtD
Sildenafil—Nausea—Methotrexate—breast cancer	9.76e-06	5.62e-05	CcSEcCtD
Sildenafil—Diarrhoea—Doxorubicin—breast cancer	9.73e-06	5.6e-05	CcSEcCtD
Sildenafil—Rash—Epirubicin—breast cancer	9.69e-06	5.58e-05	CcSEcCtD
Sildenafil—Dermatitis—Epirubicin—breast cancer	9.68e-06	5.57e-05	CcSEcCtD
Sildenafil—Headache—Epirubicin—breast cancer	9.63e-06	5.54e-05	CcSEcCtD
Sildenafil—Dizziness—Doxorubicin—breast cancer	9.41e-06	5.41e-05	CcSEcCtD
Sildenafil—Nausea—Epirubicin—breast cancer	9.13e-06	5.26e-05	CcSEcCtD
Sildenafil—Vomiting—Doxorubicin—breast cancer	9.04e-06	5.21e-05	CcSEcCtD
Sildenafil—Rash—Doxorubicin—breast cancer	8.97e-06	5.16e-05	CcSEcCtD
Sildenafil—Dermatitis—Doxorubicin—breast cancer	8.96e-06	5.16e-05	CcSEcCtD
Sildenafil—Headache—Doxorubicin—breast cancer	8.91e-06	5.13e-05	CcSEcCtD
Sildenafil—Nausea—Doxorubicin—breast cancer	8.45e-06	4.86e-05	CcSEcCtD
Sildenafil—CYP3A5—Metabolism—PLA2G4A—breast cancer	2.46e-06	2.84e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NCOA2—breast cancer	2.45e-06	2.84e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL8—breast cancer	2.44e-06	2.82e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.43e-06	2.81e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTA2—breast cancer	2.42e-06	2.8e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GPX2—breast cancer	2.42e-06	2.8e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—breast cancer	2.42e-06	2.8e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP3A4—breast cancer	2.42e-06	2.8e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.4e-06	2.78e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—FASN—breast cancer	2.4e-06	2.78e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GPX4—breast cancer	2.39e-06	2.77e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SULT1A1—breast cancer	2.39e-06	2.77e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCB1—breast cancer	2.39e-06	2.77e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—BCHE—breast cancer	2.39e-06	2.76e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1B—breast cancer	2.38e-06	2.75e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—FASN—breast cancer	2.38e-06	2.75e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1B1—breast cancer	2.38e-06	2.75e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—BCHE—breast cancer	2.37e-06	2.74e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC5A5—breast cancer	2.36e-06	2.73e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GPX1—breast cancer	2.36e-06	2.73e-05	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—breast cancer	2.36e-06	2.72e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GPX1—breast cancer	2.35e-06	2.72e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TYMS—breast cancer	2.35e-06	2.72e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—breast cancer	2.34e-06	2.71e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC5A5—breast cancer	2.34e-06	2.71e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTA1—breast cancer	2.34e-06	2.71e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—IDH1—breast cancer	2.34e-06	2.71e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP1A1—breast cancer	2.33e-06	2.7e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP3—breast cancer	2.33e-06	2.7e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HSP90AA1—breast cancer	2.33e-06	2.7e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL2—breast cancer	2.33e-06	2.7e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP1A1—breast cancer	2.33e-06	2.69e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTM1—breast cancer	2.32e-06	2.69e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NCOR1—breast cancer	2.32e-06	2.69e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PLA2G4A—breast cancer	2.32e-06	2.69e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL6—breast cancer	2.32e-06	2.68e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ERCC2—breast cancer	2.31e-06	2.68e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NAT2—breast cancer	2.31e-06	2.68e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ERCC2—breast cancer	2.31e-06	2.67e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—breast cancer	2.28e-06	2.64e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NQO1—breast cancer	2.28e-06	2.64e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC2A1—breast cancer	2.28e-06	2.64e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—breast cancer	2.27e-06	2.63e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NCOA1—breast cancer	2.27e-06	2.62e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—JUN—breast cancer	2.27e-06	2.62e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC2A1—breast cancer	2.26e-06	2.61e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NQO1—breast cancer	2.26e-06	2.61e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CTNNB1—breast cancer	2.25e-06	2.6e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—STK11—breast cancer	2.23e-06	2.58e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP19A1—breast cancer	2.23e-06	2.58e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP3A4—breast cancer	2.22e-06	2.57e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GPX1—breast cancer	2.22e-06	2.57e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CD—breast cancer	2.22e-06	2.57e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.21e-06	2.56e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—breast cancer	2.2e-06	2.55e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP3A4—breast cancer	2.2e-06	2.55e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1A—breast cancer	2.2e-06	2.54e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.19e-06	2.54e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTEN—breast cancer	2.19e-06	2.54e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ALB—breast cancer	2.19e-06	2.53e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1B1—breast cancer	2.19e-06	2.53e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ERCC2—breast cancer	2.18e-06	2.52e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MTHFR—breast cancer	2.18e-06	2.52e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MTHFR—breast cancer	2.17e-06	2.51e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1B1—breast cancer	2.17e-06	2.51e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK8—breast cancer	2.14e-06	2.48e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.14e-06	2.48e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—breast cancer	2.14e-06	2.47e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.12e-06	2.46e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.1e-06	2.43e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—NOS3—breast cancer	2.09e-06	2.42e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NCOA1—breast cancer	2.08e-06	2.41e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—COMT—breast cancer	2.08e-06	2.4e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTP1—breast cancer	2.07e-06	2.39e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NCOA1—breast cancer	2.07e-06	2.39e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP19A1—breast cancer	2.05e-06	2.38e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—STK11—breast cancer	2.05e-06	2.38e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MTHFR—breast cancer	2.05e-06	2.37e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HMOX1—breast cancer	2.04e-06	2.36e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP19A1—breast cancer	2.04e-06	2.36e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—STK11—breast cancer	2.04e-06	2.36e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ITPR1—breast cancer	2.03e-06	2.35e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SRC—breast cancer	2.03e-06	2.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MED12—breast cancer	2.03e-06	2.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—DPYD—breast cancer	2.03e-06	2.35e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CAV1—breast cancer	2.01e-06	2.32e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CAV1—breast cancer	2e-06	2.32e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALDOA—breast cancer	2e-06	2.31e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—breast cancer	1.98e-06	2.29e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—breast cancer	1.96e-06	2.27e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCB1—breast cancer	1.96e-06	2.26e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NCOA3—breast cancer	1.94e-06	2.24e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CB—breast cancer	1.93e-06	2.24e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC2A2—breast cancer	1.92e-06	2.23e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TYMS—breast cancer	1.92e-06	2.22e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—breast cancer	1.92e-06	2.22e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—breast cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—COMT—breast cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTP1—breast cancer	1.9e-06	2.2e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.9e-06	2.2e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NCOR1—breast cancer	1.9e-06	2.2e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTM1—breast cancer	1.9e-06	2.2e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—COMT—breast cancer	1.89e-06	2.19e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CAV1—breast cancer	1.89e-06	2.19e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CPT1A—breast cancer	1.89e-06	2.18e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MTR—breast cancer	1.89e-06	2.18e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCG2—breast cancer	1.89e-06	2.18e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTP1—breast cancer	1.88e-06	2.18e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HMOX1—breast cancer	1.87e-06	2.17e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK3—breast cancer	1.87e-06	2.17e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ITPR1—breast cancer	1.87e-06	2.16e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HMOX1—breast cancer	1.86e-06	2.15e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ITPR1—breast cancer	1.85e-06	2.15e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HPGDS—breast cancer	1.85e-06	2.14e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HBA1—breast cancer	1.84e-06	2.13e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CG—breast cancer	1.83e-06	2.11e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CG—breast cancer	1.82e-06	2.11e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—breast cancer	1.82e-06	2.11e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GPX1—breast cancer	1.82e-06	2.1e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TGFB1—breast cancer	1.82e-06	2.1e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.81e-06	2.09e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1A1—breast cancer	1.8e-06	2.08e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCB1—breast cancer	1.8e-06	2.08e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTT1—breast cancer	1.79e-06	2.07e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ACHE—breast cancer	1.79e-06	2.07e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ERCC2—breast cancer	1.79e-06	2.07e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCB1—breast cancer	1.78e-06	2.06e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—breast cancer	1.78e-06	2.06e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TYMS—breast cancer	1.77e-06	2.04e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TYMS—breast cancer	1.75e-06	2.03e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTM1—breast cancer	1.75e-06	2.02e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NCOR1—breast cancer	1.75e-06	2.02e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.75e-06	2.02e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.73e-06	2e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTM1—breast cancer	1.73e-06	2e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NCOR1—breast cancer	1.73e-06	2e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CG—breast cancer	1.72e-06	1.99e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP17A1—breast cancer	1.7e-06	1.96e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—breast cancer	1.68e-06	1.95e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS1—breast cancer	1.68e-06	1.94e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ENO1—breast cancer	1.68e-06	1.94e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MTHFR—breast cancer	1.68e-06	1.94e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GPX1—breast cancer	1.67e-06	1.94e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTEN—breast cancer	1.67e-06	1.93e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GPX1—breast cancer	1.66e-06	1.92e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1A1—breast cancer	1.66e-06	1.92e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2D6—breast cancer	1.65e-06	1.91e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ERCC2—breast cancer	1.64e-06	1.9e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1A1—breast cancer	1.64e-06	1.9e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ERCC2—breast cancer	1.63e-06	1.88e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NCOA2—breast cancer	1.62e-06	1.87e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CD—breast cancer	1.61e-06	1.86e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CD—breast cancer	1.6e-06	1.86e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALB—breast cancer	1.59e-06	1.84e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALB—breast cancer	1.58e-06	1.83e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—FASN—breast cancer	1.57e-06	1.81e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—BCHE—breast cancer	1.56e-06	1.81e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CAV1—breast cancer	1.55e-06	1.79e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—breast cancer	1.55e-06	1.79e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MTHFR—breast cancer	1.54e-06	1.79e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC5A5—breast cancer	1.54e-06	1.78e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MTHFR—breast cancer	1.53e-06	1.77e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—NOS3—breast cancer	1.52e-06	1.76e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CD—breast cancer	1.52e-06	1.75e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—NOS3—breast cancer	1.51e-06	1.75e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—breast cancer	1.5e-06	1.73e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALB—breast cancer	1.5e-06	1.73e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NQO1—breast cancer	1.49e-06	1.72e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC2A1—breast cancer	1.49e-06	1.72e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.48e-06	1.71e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—breast cancer	1.43e-06	1.66e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NOS3—breast cancer	1.43e-06	1.66e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1B1—breast cancer	1.43e-06	1.65e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CAV1—breast cancer	1.42e-06	1.65e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CAV1—breast cancer	1.41e-06	1.63e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CG—breast cancer	1.41e-06	1.63e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.4e-06	1.62e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CB—breast cancer	1.4e-06	1.62e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CB—breast cancer	1.4e-06	1.62e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—breast cancer	1.39e-06	1.61e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—breast cancer	1.39e-06	1.6e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6—breast cancer	1.37e-06	1.58e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NCOA1—breast cancer	1.36e-06	1.58e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.35e-06	1.56e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—STK11—breast cancer	1.34e-06	1.55e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP19A1—breast cancer	1.34e-06	1.55e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CB—breast cancer	1.32e-06	1.53e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—breast cancer	1.31e-06	1.51e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CG—breast cancer	1.3e-06	1.5e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CG—breast cancer	1.29e-06	1.49e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—breast cancer	1.26e-06	1.46e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—COMT—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTP1—breast cancer	1.24e-06	1.44e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CD—breast cancer	1.24e-06	1.43e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HMOX1—breast cancer	1.23e-06	1.42e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALB—breast cancer	1.22e-06	1.42e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ITPR1—breast cancer	1.22e-06	1.41e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTEN—breast cancer	1.21e-06	1.4e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTEN—breast cancer	1.21e-06	1.4e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—breast cancer	1.18e-06	1.36e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCB1—breast cancer	1.18e-06	1.36e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NOS3—breast cancer	1.17e-06	1.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TYMS—breast cancer	1.16e-06	1.34e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.14e-06	1.32e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NCOR1—breast cancer	1.14e-06	1.32e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTM1—breast cancer	1.14e-06	1.32e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTEN—breast cancer	1.14e-06	1.32e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CD—breast cancer	1.14e-06	1.32e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CD—breast cancer	1.13e-06	1.31e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALB—breast cancer	1.13e-06	1.3e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALB—breast cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GPX1—breast cancer	1.09e-06	1.27e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1A1—breast cancer	1.08e-06	1.25e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CB—breast cancer	1.08e-06	1.25e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NOS3—breast cancer	1.08e-06	1.25e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ERCC2—breast cancer	1.07e-06	1.24e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—breast cancer	1.07e-06	1.24e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NOS3—breast cancer	1.07e-06	1.23e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MTHFR—breast cancer	1.01e-06	1.17e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CB—breast cancer	9.94e-07	1.15e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CB—breast cancer	9.85e-07	1.14e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—breast cancer	9.85e-07	1.14e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—breast cancer	9.76e-07	1.13e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—breast cancer	9.63e-07	1.11e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTEN—breast cancer	9.34e-07	1.08e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CAV1—breast cancer	9.31e-07	1.08e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTEN—breast cancer	8.59e-07	9.94e-06	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—breast cancer	8.54e-07	9.88e-06	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—breast cancer	8.52e-07	9.86e-06	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTEN—breast cancer	8.51e-07	9.85e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CG—breast cancer	8.48e-07	9.81e-06	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—breast cancer	8.05e-07	9.31e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CD—breast cancer	7.46e-07	8.62e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALB—breast cancer	7.36e-07	8.51e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NOS3—breast cancer	7.04e-07	8.14e-06	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—breast cancer	6.98e-07	8.07e-06	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—breast cancer	6.96e-07	8.05e-06	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—breast cancer	6.59e-07	7.62e-06	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—breast cancer	6.58e-07	7.61e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CB—breast cancer	6.5e-07	7.52e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—breast cancer	6.44e-07	7.45e-06	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—breast cancer	6.06e-07	7.01e-06	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—breast cancer	6.01e-07	6.95e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTEN—breast cancer	5.62e-07	6.5e-06	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—breast cancer	5.38e-07	6.23e-06	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—breast cancer	4.95e-07	5.73e-06	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—breast cancer	4.91e-07	5.68e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—breast cancer	3.96e-07	4.58e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—breast cancer	3.24e-07	3.74e-06	CbGpPWpGaD
